S. Ramjug (Altrincham, United Kingdom), O. Sitbon (Le Kremlin-Bicêtre, France)
Introduction
S. Ramjug (Altrincham, United Kingdom), O. Sitbon (Le Kremlin-Bicêtre, France)
|  |
Impact of pulmonary arterial hypertension on employment, work productivity and quality of life - results of a cross-sectional multi-center study
J. Fuge (Hannover, Germany), D. Park (Hannover, Germany), T. Von Lengerke (Hannover, Germany), M. Richter (Giessen, Germany), H. Gall (Giessen, Germany), H. Ghofrani (Giessen, Germany), J. Kamp (Hannover, Germany), M. Hoeper (Hannover, Germany), K. Olsson (Hannover, Germany)
|    |
A combined measure of pulmonary vascular resistence and compliance variations in Pulmonary Hypertension (PH)
E. Airò (Pisa (PI), Italy), C. Bauleo (Pisa (PI), Italy), R. Prediletto (Pisa (PI), Italy), B. Formichi (Pisa (PI), Italy), I. Pavlickova (Pisa (PI), Italy), M. Raciti (Pisa (PI), Italy), S. Monti (Pisa (PI), Italy)
| |
Effect of sotatercept on multicomponent improvement in the PULSAR study
M. Hoeper (Hannover, Germany), H. Ghofrani (Giessen, Germany), J. Gibbs (London, United Kingdom), M. Gomberg-Maitland (Washington DC, United States), M. Humbert (Le Kremlin-Bicêtre, France), V. Mclaughlin (Ann Arbor, MI, United States), I. Preston (Boston, MA, United States), R. Souza (São Paulo, Brazil), A. Waxman (Boston, MA, United States), J. Pena (Rahway, NJ, United States), S. Manimaran (Rahway, NJ, United States), M. Fowler (Rahway, NJ, United States), D. Badesch (Aurora, CO, United States)
| |
Characteristics and management of chronic thromboembolic pulmonary disease patients without pulmonary hypertension in an expert centre
B. Lechartier (Le Kremlin-Bicêtre, France), M. Jevnikar (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), P. Brenot (Le Plessis Robinson, France), A. Beurnier (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France)
| |
Metabolic modulation of the right ventricle and pulmonary circulation in pulmonary arterial hypertension: an interventional study using a Glucagon-like-peptide-1 (GLP-1) agonist
C. Samaranayake (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), J. Pinguel (London, United Kingdom), E. Morris (London, United Kingdom), E. Moriarty (London, United Kingdom), M. Gummadi (London, United Kingdom), K. Dimopoulos (London, United Kingdom), S. Wort (London, United Kingdom), L. Zhao (London, United Kingdom), C. Mccabe (London, United Kingdom)
| |
Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry
G. Kovacs (Graz, Austria), M. Humbert (Paris, France), P. Herve (Paris, France), A. Avian (Graz, Austria), N. Galie (Bologna, Italy), G. Lewis (Boston, United States), R. Souza (Sao Paulo, Brazil), S. Ulrich (Zurich, Switzerland), A. Vonk Noordegraaf (Amsterdam, Netherlands), M. Andersen (Aarhus, Denmark), J. Barbera (Barcelona, Spain), I. Blanco (Barcelona, Spain), R. Condliffe (Sheffield, United Kingdom), M. D'Alto (Naples, Italy), B. Egenlauf (Heidelberg, Germany), R. Ewert (Greifswald, Germany), E. Gruenig (Heidelberg, Germany), A. Heine (Greifswald, Germany), S. Herkenrath (Bergisch Gladbach, Germany), S. Hsu (Baltimore, United States), K. Kasperowicz (Otwock, Poland), S. Mak (Toronto, Canada), B. Maron (Boston, United States), C. Mccabe (London, United Kingdom), R. Oliveira (Sao Paulo, Brazil), S. Rosenkranz (Cologne, Germany), L. Savale (Paris, France), S. Saxer (Zurich, Switzerland), D. Systrom (Graz, United States), R. Tedford (Charleston, United States), A. Torbicki (Otwock, Poland), H. Olschewski (Graz, Austria)
| |
New diagnostic criteria and PVR thresholds in SSc-associated PH: Insights from the ASPIRE registry
A. Haque (Sheffield (South Yorkshire), United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), K. Dwivedi (Sheffield (South Yorkshire), United Kingdom), C. Elliot (Sheffield (South Yorkshire), United Kingdom), A. Hameed (Sheffield (South Yorkshire), United Kingdom), N. Hamilton (Sheffield (South Yorkshire), United Kingdom), R. Lewis (Sheffield (South Yorkshire), United Kingdom), S. Ramjug (Sheffield (South Yorkshire), United Kingdom), A. Rothman (Sheffield (South Yorkshire), United Kingdom), R. Thompson (Sheffield (South Yorkshire), United Kingdom), A. Swift (Sheffield (South Yorkshire), United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom)
| |
The preponderance of genetic involvement in paediatric pulmonary hypertension
J. GRYNBLAT (Paris, France), S. Malekzadeh Milani (Paris, France), M. Meot (Paris, France), I. Szezepanski (Paris, France), M. Levy (Paris, France), D. Bonnet (Paris, France)
| |
Inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease: event-free survival in INCREASE study open-label extension
S. Nathan (Falls Church, United States), R. Argula (Mount Pleasant, United States), S. Rajagopal (Durham, United States), S. Johri (Richmond, United States), D. De La Zerda (Miami, United States), D. Mcglothlin (San Francisco, United States), P. Smith (Durham, United States), C. Deng (Durham, United States), M. Miceli (Durham, United States), V. Tapson (Los Angeles, United States), A. Waxman (Boston, United States)
| |
Late Breaking Abstract - Risk stratification in pulmonary veno-occlusive disease
A. Boucly (Le Kremlin Bicètre, France), L. Savale (Le Kremlin Bicètre, France), X. Jaïs (Le Kremlin Bicètre, France), A. Beurnier (Le Kremlin Bicètre, France), M. Jevnikar (Le Kremlin Bicètre, France), M. Humbert (Le Kremlin Bicètre, France), O. Sitbon (Le Kremlin Bicètre, France), D. Montani (Le Kremlin Bicètre, France)
| |